4/8
02:07 am
eigr
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/4
01:08 pm
eigr
BRNS, UPC and KWE among mid-day movers [Seeking Alpha]
Low
Report
BRNS, UPC and KWE among mid-day movers [Seeking Alpha]
4/1
11:16 am
eigr
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection [Yahoo! Finance]
High
Report
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection [Yahoo! Finance]
4/1
11:12 am
eigr
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
High
Report
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
3/31
02:09 am
eigr
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/23
02:10 am
eigr
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/15
02:28 am
eigr
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/7
02:07 am
eigr
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/28
02:06 am
eigr
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/20
02:15 am
eigr
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/12
01:10 am
eigr
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/4
01:14 am
eigr
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/27
04:48 am
eigr
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/20
10:03 am
eigr
First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan [Yahoo! Finance]
Medium
Report
First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan [Yahoo! Finance]
1/19
01:08 am
eigr
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/18
05:55 pm
eigr
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan [Yahoo! Finance]
Medium
Report
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan [Yahoo! Finance]
1/18
05:49 pm
eigr
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan
Medium
Report
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan